ClinicalTrials.Veeva

Menu

Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach(Radiogenomics-Urinary)

H

Huazhong University of Science and Technology

Status

Enrolling

Conditions

Urologic Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;
  2. Aged > 18 years old;
  3. At least one CT scan or MRI scan before treatment;
  4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion criteria:

  1. Poor image quality;
  2. Incomplete clinical data or loss of follow-up;
  3. Presence of another primary malignancy other than urologic cancer;
  4. Unclear pathological diagnosis。

Trial contacts and locations

1

Loading...

Central trial contact

Lian Yang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems